Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • AChR
    (1)
  • Aminopeptidase
    (1)
  • Drug Metabolite
    (1)
  • Histone Methyltransferase
    (1)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Metabolism
    (2)
  • Cancer
    (1)
  • Immune System
    (1)
  • Infection
    (1)
  • Inflammation
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

T1987

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
PFI-2
PFI2, PFI 2, (R)-PFI-2
T19871627676-59-8
PFI-2 is an effective, specific and cell-active lysine methyltransferase SETD7 inhibitor (Ki/IC50: 0.33/2 nM), 1000-fold selectivity over other methyltransferases and other non-epigenetic targets.
  • $38
In Stock
Size
QTY
Aceclidine
Quinuclidin-3-yl acetate, NSC-657843, NSC657843, NSC 657843, Glaucostat, 3-quinuclidinyl acetate, 3-Acetoxyquinuclidine, 1-azabicyclo[2.2.2]octan-3-yl acetate
T19870827-61-2
Aceclidine (1-azabicyclo[2.2.2]octan-3-yl acetate) is a modulator of M3 mAChR and can be used in studies about treating glaucoma by reducing intraocular pressure.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Beloranib
ZGN 440, CKD-732
T19871251111-30-5
Beloranib is a fumagillin anticancer drug. Beloranib belongs to an angiogenesis inhibitor.
  • $3,920
3-6 months
Size
QTY
Edoxaban M4
UNII-IV344R972X, Edoxaban 4-Carboxylic Acid, D21-2393, D21 2393
T19873834919-19-6
D21-2393 subjects received a single-oral-dose of edoxaban 30-90 mg in each study occasion under fasting condition. Serial blood samples were collected to measure the plasma concentrations of edoxaban and its major active metabolite D21-2393. Meanwhile, PT, INR, aPTT were measured pre- and post-dose.
    Inquiry